Clinical characteristics of tumours showing incomplete clinical response
| Age (years) | Gender | Eye | Location | Limbus involvement* | LBD | Thickness >1.5 mm | Fornix involvement | Tarsal involvement | Multifocality | AJCC staging† | Histopathology |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 73 | M | RE | Diffuse | 5 | 15 | Yes | Yes | No | Yes | T3 | SCC |
| 62 | M | LE | Diffuse | 3 | 11 | Yes | Yes | Yes | Yes | T3 | SCC |
| 72 | M | LE | Diffuse | 8 | 18 | Yes | Yes | Yes | Yes | T3 | SCC |
| 66 | M | RE | Diffuse | 4 | 15 | Yes | Yes | Yes | Yes | T3 | SCC |
| 55 | M | RE | Diffuse | 6 | 17 | No | Yes | Yes | Yes | T3 | HGD |
| 74 | F | RE | Bulbar | NA | 3 | Yes | No | No | No | T1 | LGD |
| 63 | F | LE | Limbal | 3 | 6 | No | No | No | No | T2 | HGD |
*In clock hours.
†AJCC staging system.
AJCC, American Joint Committee on Cancer; F, female; HGD, high-grade dysplasia; LBD, largest basal diameter; LE, left eye; LGD, low-grade dysplasia; M, male; RE, right eye; SCC, squamous cell carcinoma.